Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Gains from Investment Securities (2016 - 2024)

cbdMD's Gains from Investment Securities history spans 10 years, with the latest figure at -$2.9 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 59921.79% year-over-year to -$2.9 million; the TTM value through Jun 2025 reached $2.9 million, up 7983.97%, while the annual FY2023 figure was $42180.0, 100.5% up from the prior year.
  • Gains from Investment Securities for Q3 2025 was -$2.9 million at cbdMD, down from $1.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.7 million in Q2 2025 and bottomed at -$6.9 million in Q2 2021.
  • The 5-year median for Gains from Investment Securities is -$18347.5 (2023), against an average of -$437104.5.
  • The largest annual shift saw Gains from Investment Securities soared 4800.94% in 2021 before it tumbled 59921.79% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $366841.0 in 2021, then crashed by 116.63% to -$61000.0 in 2022, then skyrocketed by 47.76% to -$31867.0 in 2023, then skyrocketed by 3754.73% to $1.2 million in 2024, then plummeted by 347.99% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Gains from Investment Securities are -$2.9 million (Q3 2025), $1.7 million (Q2 2025), and $1.2 million (Q4 2024).